id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_nwhwizozlvgs3cuql4wnqj4tly	Mathew Varghese	Aspirin-Exacerbated Asthma	2008	9	.pdf	application/pdf	6476	746	55	This review focuses on aspirin-exacerbated asthma (AEA). Aspirin affects both of these pathways by inhibiting the enzyme cycooxygenase-1 (COX-1). asthma after ingestion of aspirin, nasal congestion, watery rhinorrhea and nasal polyposis. eosinophilic rhinosinusitis, nasal polyposis, aspirin sensitivity, and asthma. (NSAIDs), including aspirin, induce bronchospasm, rhinorrhea, and nasal obstruction in these subjects. ingestion of aspirin and other COX-1 inhibiting NSAIDs. AEA is used to refer to this syndrome throughout this AEA 5 aspirin-exacerbated asthma; ASA 5 acetylsalicylic acid; GI 5 other case reports of AEA improving after aspirin asthma, aspirin sensitivity, and then nasal polyposis. asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Prostaglandin E2 and aspirin-induced asthma. asthma, nasal polyps and aspirin intolerance. Aspirin-induced bronchial asthma in sisters. Clinical course of aspirin-induced asthma: COX-2 inhibitor in aspirin-induced asthma. inhibitor in patients with aspirin-induced asthma. in aspirin sensitive subjects with asthma. leukotriene-modifier drugs on aspirin-induced asthma and rhinitis	./cache/work_nwhwizozlvgs3cuql4wnqj4tly.pdf	./txt/work_nwhwizozlvgs3cuql4wnqj4tly.txt